Cargando…
A Perspective on Nanotechnology and COVID-19 Vaccine Research and Production in South Africa
Advances in nanotechnology have enabled the development of a new generation of vaccines, which are playing a critical role in the global control of the COVID-19 pandemic and the return to normalcy. Vaccine development has been conducted, by and large, by countries in the global north. South Africa,...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539279/ https://www.ncbi.nlm.nih.gov/pubmed/34696526 http://dx.doi.org/10.3390/v13102095 |
_version_ | 1784588708493656064 |
---|---|
author | Dube, Admire Egieyeh, Samuel Balogun, Mohammed |
author_facet | Dube, Admire Egieyeh, Samuel Balogun, Mohammed |
author_sort | Dube, Admire |
collection | PubMed |
description | Advances in nanotechnology have enabled the development of a new generation of vaccines, which are playing a critical role in the global control of the COVID-19 pandemic and the return to normalcy. Vaccine development has been conducted, by and large, by countries in the global north. South Africa, as a major emerging economy, has made extensive investments in nanotechnology and bioinformatics and has the expertise and resources in vaccine development and manufacturing. This has been built at a national level through decades of investment. In this perspective article, we provide a synopsis of the investments made in nanotechnology and highlight how these could support innovation, research, and development for vaccines for this disease. We also discuss the application of bioinformatics tools to support rapid and cost-effective vaccine development and make recommendations for future research and development in this area to support future health challenges. |
format | Online Article Text |
id | pubmed-8539279 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-85392792021-10-24 A Perspective on Nanotechnology and COVID-19 Vaccine Research and Production in South Africa Dube, Admire Egieyeh, Samuel Balogun, Mohammed Viruses Perspective Advances in nanotechnology have enabled the development of a new generation of vaccines, which are playing a critical role in the global control of the COVID-19 pandemic and the return to normalcy. Vaccine development has been conducted, by and large, by countries in the global north. South Africa, as a major emerging economy, has made extensive investments in nanotechnology and bioinformatics and has the expertise and resources in vaccine development and manufacturing. This has been built at a national level through decades of investment. In this perspective article, we provide a synopsis of the investments made in nanotechnology and highlight how these could support innovation, research, and development for vaccines for this disease. We also discuss the application of bioinformatics tools to support rapid and cost-effective vaccine development and make recommendations for future research and development in this area to support future health challenges. MDPI 2021-10-18 /pmc/articles/PMC8539279/ /pubmed/34696526 http://dx.doi.org/10.3390/v13102095 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Perspective Dube, Admire Egieyeh, Samuel Balogun, Mohammed A Perspective on Nanotechnology and COVID-19 Vaccine Research and Production in South Africa |
title | A Perspective on Nanotechnology and COVID-19 Vaccine Research and Production in South Africa |
title_full | A Perspective on Nanotechnology and COVID-19 Vaccine Research and Production in South Africa |
title_fullStr | A Perspective on Nanotechnology and COVID-19 Vaccine Research and Production in South Africa |
title_full_unstemmed | A Perspective on Nanotechnology and COVID-19 Vaccine Research and Production in South Africa |
title_short | A Perspective on Nanotechnology and COVID-19 Vaccine Research and Production in South Africa |
title_sort | perspective on nanotechnology and covid-19 vaccine research and production in south africa |
topic | Perspective |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539279/ https://www.ncbi.nlm.nih.gov/pubmed/34696526 http://dx.doi.org/10.3390/v13102095 |
work_keys_str_mv | AT dubeadmire aperspectiveonnanotechnologyandcovid19vaccineresearchandproductioninsouthafrica AT egieyehsamuel aperspectiveonnanotechnologyandcovid19vaccineresearchandproductioninsouthafrica AT balogunmohammed aperspectiveonnanotechnologyandcovid19vaccineresearchandproductioninsouthafrica AT dubeadmire perspectiveonnanotechnologyandcovid19vaccineresearchandproductioninsouthafrica AT egieyehsamuel perspectiveonnanotechnologyandcovid19vaccineresearchandproductioninsouthafrica AT balogunmohammed perspectiveonnanotechnologyandcovid19vaccineresearchandproductioninsouthafrica |